de Wit, M. and Laack, E. and Schulz, C. and Wolff, T. and Rueckert, A. and Reck, M. and Faehling, M. and Fischer, J. (2018) PACIFIC: A double-blind, placebo-controlled phase III study of durvalumab after chemoradiation therapy in patients with stage III, locally advanced, unresectable NSCLC. STRAHLENTHERAPIE UND ONKOLOGIE, 194 (Suppl1). S24. ISSN 0179-7158, 1439-099X
Full text not available from this repository.Item Type: | Article |
---|---|
Subjects: | 600 Technology > 610 Medical sciences Medicine |
Divisions: | Medicine > Lehrstuhl für Innere Medizin II |
Depositing User: | Petra Gürster |
Date Deposited: | 02 Jul 2020 05:24 |
Last Modified: | 02 Jul 2020 05:24 |
URI: | https://pred.uni-regensburg.de/id/eprint/14470 |
Actions (login required)
View Item |